School of Medicine


Showing 21-40 of 67 Results

  • Fatih Inci

    Fatih Inci

    Affiliate, Rad/Canary Center at Stanford for Cancer Early Detection

    Bio Dr. Fatih Inci is currently working as a Research Scientist at Stanford University School of Medicine, Canary Center at Stanford for Cancer Early Detection. He has been guiding and working with a group of researchers, including postdoctoral fellows, graduate, undergraduate, and high school students, who focus on micro- and nano-technologies for biomedical and bioengineering applications. Dr. Inci received his B.Sc. degree at the Department of Molecular Biology and Genetics in 2007 with magna cum laude honor from Istanbul University (Turkey), and also studied as an Sokrates student at the Department of Biology in University of Groningen (Netherlands) in 2005. He received his Ph.D. degree at the Department of Molecular Biology-Genetics & Biotechnology with summa cum laude honor from Istanbul Technical University (Turkey) in 2013. During his Ph.D. studies, he was also appointed as a visiting scientist at University of New South Wales (Sydney, Australia) and University of Technology Sydney (Australia), as well as working as a research scholar/trainee at Brigham and Women?s Hospital (BWH)-Harvard Medical School, and Harvard-MIT Health Sciences and Technology Division (Boston, MA). Upon the completion of his Ph.D. studies, Dr. Inci worked as a postdoctoral research fellow at BWH-Harvard Medical School (2013-2014) and Stanford University School of Medicine (2014-2015).

    Dr. Inci has published his research work in the most prestigious journals, including Proceedings of the National Academy of Sciences of the United States of America (PNAS), ACS Nano, Nature Scientific Reports, Nature Light: Science & Applications, Small, Lab on a chip, Advanced Science, Biomacromolecules, Advanced Drug Delivery Reviews, ACS Chemical Reviews, Biotechnology Advances, Annual Review of Medicine, Materials Today, Trends in Biotechnology. Besides his research publications, he has contributed to the publication of 7 book chapters (including 3 chapters in press) and 3 editorial/perspective papers. He is also editing 3 scientific books in the world's renowned publishers, i.e., Springer Press and World Scientific Publishing Company. His research findings have been presented in national and international conferences, ranging in geography from Barcelona to Osaka, Sydney to Boston, Rio de Janeiro to San Diego and Phoenix to San Francisco. Moreover, he has secured his research findings, technological developments, and scientific discoveries with 6 U.S. patents. Some of them have already been licensed by companies to produce commercial products in the United States, and distributed throughout the world. One such example is his patent in the field of forensics that has been translated into two viable commercial products (CSI-Q and NGDE) produced in the United States by DxNow, Inc.

    Dr. Inci?s qualified scientific work has been highlighted and recognized by well-renowned national and international organizations as well as government entities, including National Institute of Health, Nature Medicine, Science AAAS, Popular Science, Newsweek, Boston University, Canary Center-Stanford University, Brigham & Women?s Hospital, A*STAR, Center for Integration of Medicine and Innovative Technology (CIMIT), and Epilepsy Foundation. He has also been awarded with various scholarships and grants from European Molecular Biology Organization-European Science Foundation (EMBO-ESF), American Chemical Society, and Turkey Scientific and Technological Research Society (TUBITAK). He is a professional member at the world?s largest and most prestigious scientific societies, including the American Association for the Advancement of Science (AAAS), Royal Society of Chemistry (RSC), American Association for Cancer Research (AACR), and National Postdoctoral Association (NPA).

  • Erik Ingelsson

    Erik Ingelsson

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests We are interested in the link between metabolic disturbances, such as obesity and insulin resistance, and the development of cardiovascular disease. Our research is translational and interdisciplinary, combining population-based studies with molecular biology to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel drug targets.

  • Alexander Ioannidis

    Alexander Ioannidis

    Postdoctoral Research Fellow, Biomedical Data Sciences

    Bio Alexander graduated from Harvard in Chemistry and Physics and earned an MPhil in Computational Biology from the University of Cambridge. Prior to Stanford, he worked in superconducting computing research at Northrop Grumman. He is a PhD graduate of Stanford's Institute for Computational and Mathematical Engineering, where he teaches machine learning and data science. As a current postdoctoral scholar, his research focues on applying computational methods to problems in human population genetics.

  • John P.A. Ioannidis

    John P.A. Ioannidis

    C. F. Rehnborg Professor in Disease Prevention in the School of Medicine, Professor of Medicine, of Health Research and Policy (Epidemiology) and by courtesy, of Statistics and of Biomedical Data Science

    Current Research and Scholarly Interests Meta-research
    Evidence-based medicine
    Clinical and molecular epidemiology
    Human genome epidemiology
    Research design
    Reporting of research
    Empirical evaluation of bias in research
    Randomized trials
    Statistical methods and modeling
    Meta-analysis and large-scale evidence
    Prognosis, predictive, personalized, precision medicine and health
    Sociology of science

  • Cristiana Iosef

    Cristiana Iosef

    Basic Life Science Research Scientist, Cardiothoracic Surgery

    Bio Dr. Cristiana Iosef returned to Stanford University Medical School in Feb 2019, after serving for five years, as a research associate professor of Pharmacology, in the Nevada State University. Enthusiastically, Cristiana joined Dr Michael Fischbein?s research program in the Department of Cardiothoracic Surgery, and she will focus on the molecular cues leading to vascular aneurysms. The long-term goal is to design high precision personalized therapies based on induced pluripotent stem cells (iPSC) aimed to restore the defective signaling pathways associated with cardio-vascular pathologies, or to predict their evolution. This collaboration started in 2010 while being a member of the Stanford/Pediatrics Department (Alvira lab) and yielded an important publication: Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao PS, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res. 2012 Jan 20;110(2):312-24. Dr Iosef is a dvm-surgeon and molecular signaling expert and she began her research career as a Fulbright Graduate Scholar in Washington University School of Medicine (St Louis, MO). She continued to specialize in animal models for human medicine practice in the Ohio State University. Prior to joining Stanford University in 2010, Cristiana developed an important body of work on signal-transduction and proteomic profiling of placental mesenchymal stem cells, in the University of Western Ontario, Canada (2001-10). In addition to her academic duties, Cristiana served as an associate director of the Mountain West Clinical Translational Research Consortium (2016-19). When she is not in the lab, Dr Iosef can be found hiking on the Pacific coast, skiing in the Sierras, visiting art galleries or she may study for her brown-belt exam in martial arts at JKA Shotokan Stanford. Aside from being a devoted vet-surgeon scientist, Cristiana is the proud mom of a young corporate lawyer.

  • Eric Ip

    Eric Ip

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Bio Dr. Ip is Director of Clinical Therapeutics Curriculum for the Stanford University MSPA Program and Clinical Associate Professor in the Department of Medicine, Division of Primary Care and Population Health. He completed his Doctor of Pharmacy degree from UCSF School of Pharmacy and his post-graduate residency at Kaiser Permanente Santa Clara Medical Center. He is a clinical pharmacist specializing in diabetes and cardiovascular care. He established and currently co-leads the Diabetes Management Program at Kaiser Permanente Mountain View Medical Offices. He is also Chair and Professor of Clinical Sciences at Touro University California College of Pharmacy. Dr. Ip's research interests include anabolic steroids and performancing enhancing drugs as well as educational research.

  • Cynthia Irvine

    Cynthia Irvine

    Associate Dean, Office of Medical Education, School of Medicine - Student Affairs

    Current Role at Stanford Associate Dean, Office of Medical Education (MD Program); Co-Director, Scholarly Concentration in Medical Education

Footer Links:

Stanford Medicine Resources: